about
Soluble guanylate cyclase α1-deficient mice: a novel murine model for primary open angle glaucomaCalciphylaxis: risk factors, diagnosis, and treatmentQuantifying a rare disease in administrative data: the example of calciphylaxisSoluble Guanylate Cyclase a1-Deficient Mice: a novel murine model for Primary Open Angle GlaucomaSoluble guanylate cyclase alpha1beta1 limits stroke size and attenuates neurological injury.Inhibition of bone morphogenetic protein signal transduction prevents the medial vascular calcification associated with matrix Gla protein deficiency.LMKB/MARF1 localizes to mRNA processing bodies, interacts with Ge-1, and regulates IFI44L gene expression.Vasoreactivity to inhaled nitric oxide with oxygen predicts long-term survival in pulmonary arterial hypertensionExercise oscillatory ventilation in systolic heart failure: an indicator of impaired hemodynamic response to exercise.Progesterone receptor membrane component-1 regulates hepcidin biosynthesisInhibition of bone morphogenetic protein signaling reduces vascular calcification and atherosclerosisAn open-source computational tool to automatically quantify immunolabeled retinal ganglion cellsPulmonary Vascular Distensibility Predicts Pulmonary Hypertension Severity, Exercise Capacity, and Survival in Heart Failure.Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation.Androgen-sensitive hypertension associated with soluble guanylate cyclase-α1 deficiency is mediated by 20-HETE.Pulmonary vascular response patterns during exercise in left ventricular systolic dysfunction predict exercise capacity and outcomes.Circulating angiogenic modulatory factors predict survival and functional class in pulmonary arterial hypertensionGenetic associations with valvular calcification and aortic stenosisAdverse effects of hemorrhagic shock resuscitation with stored blood are ameliorated by inhaled nitric oxide in lambs*Predictors of survival to orthotopic heart transplant in patients with light chain amyloidosis.Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency: The IRONOUT HF Randomized Clinical Trial.Oral Iron Therapy for Heart Failure With Reduced Ejection Fraction: Design and Rationale for Oral Iron Repletion Effects on Oxygen Uptake in Heart Failure.Iron Loading Exaggerates the Inflammatory Response to the Toll-like Receptor 4 Ligand Lipopolysaccharide by Altering Mitochondrial Homeostasis.Cardiopulmonary Exercise Testing in Heart Failure.Radiation enhances the invasive potential of primary glioblastoma cells via activation of the Rho signaling pathway.Vitamin K-Dependent Carboxylation of Matrix Gla Protein Influences the Risk of Calciphylaxis.Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms.Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.The Ability of Nitric Oxide to Lower Intraocular Pressure Is Dependent on Guanylyl Cyclase.Nitric oxide regulates pulmonary vascular smooth muscle cell expression of the inducible cAMP early repressor geneExposure of Stored Packed Erythrocytes to Nitric Oxide Prevents Transfusion-associated Pulmonary Hypertension.Mammalian plasma membrane ecto-nucleoside triphosphate diphosphohydrolase 1, CD39, is not active intracellularly. The N-glycosylation state of CD39 correlates with surface activity and localization.Detection and removal of impurities in nitric oxide generated from air by pulsed electrical discharge.Soluble epoxide hydrolase deficiency or inhibition enhances murine hypoxic pulmonary vasoconstriction after lipopolysaccharide challenge.Linezolid-induced lingua villosa nigra.Increased Bone Morphogenetic Protein Signaling in the Cutaneous Vasculature of Patients with Calciphylaxis.Effect of gender on treatment and outcomes in severe aortic stenosis.Community-based primary prevention programs decrease the rate of metabolic syndrome among socioeconomically disadvantaged women.Repletion of Iron Stores With the Use of Oral Iron Supplementation in Patients With Systolic Heart Failure.A four-tier classification system of pulmonary artery metrics on computed tomography for the diagnosis and prognosis of pulmonary hypertension.
P50
Q27331498-574CF0D4-5154-4A6D-A2E8-E3D4E7EE63B0Q28084969-761AE7EF-1C90-49B2-B0E5-2891EFB9111AQ30836782-1A1DA214-5CFD-4F90-8063-C089D5B9C9D0Q33979871-EAEF6317-9AF8-477B-932E-B8356802801BQ34618219-CD449BA3-EDFF-4CDD-86D4-A81407D35C1DQ34989385-496C5BC4-1CAC-41E1-A5CB-653E617E1F36Q35155260-36E9773E-F170-4822-B8CA-D31B61D3014CQ35245746-CC399916-370B-4982-B69A-9565586E8FF5Q36152125-83FB0B67-AB44-4E6B-989A-42D4D3DE20D6Q36430759-432A97AF-C560-46AD-B1D2-BD4CDECC007BQ36921054-B5256E34-337E-4C36-A173-3CCE2A9E47B9Q36995506-F0F617B0-4972-47D9-AD87-FAE0AF33F014Q37015819-DF1FD5D9-129E-46FC-8996-BE4F0DBA353FQ37053665-C53A062A-30C8-460B-B983-B6E74C257EF4Q37071952-3D8A1214-1224-448A-9204-64080C0B1B8FQ37086877-9A64B2D6-3DB3-46A9-811A-AAA6B65300E8Q37133815-BA201240-C77D-49BB-A8CD-C5A4B73B3954Q37154922-D579D633-967F-43FC-926A-1402DA033A27Q37265746-9E6B8019-31B6-4684-85A5-48C256A0CC72Q37624857-06AA55E8-9F89-4FAC-90C0-42F9EF02FE07Q38376716-0BE1A1F5-E833-4D38-97E6-8B92E943F02DQ38393005-0B058AC3-57A3-4E77-A795-CBF3E4830B82Q38826753-7405BB13-F470-4AAF-B60F-8E3D3431996FQ38862324-F0E7C725-0D88-4466-8F88-B2B82129680BQ40366505-2F64D710-A813-4755-B5BA-9568AFB22871Q40397629-32E8D6BF-755E-48C5-BFD4-4EAE0F6F257DQ40522890-5FB6E663-0975-4B60-951F-D72E78387433Q41683734-9038509F-849E-4C06-B636-328D0C3E331BQ42286473-4C724752-3CD8-4FC6-BF9D-BC670B239BC1Q42463492-E29B7CA6-EAC9-411F-969A-9E08C1CF6A46Q42669511-F1954199-340C-4B1F-8BC1-34F3B3C9DB13Q43730427-041FF34A-96DE-4DBF-AB85-BF7CFD181CBFQ46172384-AAC46E71-3699-4A05-ABB3-CF5185661F68Q46368082-A3A1C4FA-EF13-443A-B002-E45A43408A1BQ46577443-5BE19B2E-BED4-4CD1-AE8C-020F03F03CECQ47231423-DAB4CA15-E5E2-4AB7-BAC3-D1A43E365C9EQ47356076-8304C342-A095-46F7-A7E5-1C165C172528Q48492327-7355D5A6-D9EB-41A0-90F0-791DDB1BAD12Q48795904-9F31F065-6587-4865-93AB-9F4E7CBBA061Q49647104-EB8E0395-46CF-4821-AE8F-F31ACC832E94
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Rajeev Malhotra
@ast
Rajeev Malhotra
@en
Rajeev Malhotra
@es
Rajeev Malhotra
@nl
Rajeev Malhotra
@sl
type
label
Rajeev Malhotra
@ast
Rajeev Malhotra
@en
Rajeev Malhotra
@es
Rajeev Malhotra
@nl
Rajeev Malhotra
@sl
prefLabel
Rajeev Malhotra
@ast
Rajeev Malhotra
@en
Rajeev Malhotra
@es
Rajeev Malhotra
@nl
Rajeev Malhotra
@sl
P106
P31
P496
0000-0003-0120-4630